SPECIALIST CONSULTATION

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting SPECIALIST CONSULTATION:

# Drug Count
0 ADALIMUMAB 2
1 FOSCARBIDOPA/FOSLEVODOPA 2
2 INFLIXIMAB 2
3 PREGABALIN 2
4 VUTRISIRAN 2
5 ACETAMINOPHEN 1
6 ACETAMINOPHEN 500MG 1
7 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
8 ALCOHOL 1
9 APREMILAST 1
See all common drugs associated with SPECIALIST CONSULTATION

SPECIALIST CONSULTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE 1 0.0013
1 COAGULATION FACTOR IX RECOMBINANT HUMAN 1 0.0009
2 VUTRISIRAN 2 0.0007
3 TRASTUZUMAB-ANNS 1 0.0007
4 ELAGOLIX 1 0.0003
5 FOSCARBIDOPA/FOSLEVODOPA 2 0.0002
6 BEVACIZUMAB-AWWB 1 0.0002
7 TAFAMIDIS MEGLUMINE 1 0.0002
8 CILTACABTAGENE AUTOLEUCEL 1 0.0002
9 CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES 1 0.0001
See all drugs enriched for association with SPECIALIST CONSULTATION